Nanocarriers with tunable surface properties to unblock bottlenecks in systemic drug and gene delivery

Journal of Controlled Release

Volumn 214, Issue , 2015, Pages 121-133

  Zou, Haijuan ^a   Wang, Zhongjuan ^a   Feng, Min ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Acid labile bonds; Nanocarriers; Polymer brushes; Tunable surface; Zwitterionic

Indexed keywords

CONJUGATED POLYMERS; DENDRIMERS; ENZYME ACTIVITY; ENZYME INHIBITION; GENE THERAPY; GENE TRANSFER; GENES; PRODUCT DEVELOPMENT;

ACID-LABILE; DELIVERY SYSTEMS; GENE DELIVERY SYSTEMS; MICROENVIRONMENTS; NANO-CARRIERS; POLYMER BRUSHES; THERAPEUTIC EFFICACY; ZWITTERIONIC;

SURFACE PROPERTIES;

AMPHOLYTE; NANOCARRIER; POLYMER; DRUG CARRIER; NANOMATERIAL;

CIRCULATION TIME; CONJUGATION; DISSOCIATION; DRUG DELIVERY SYSTEM; GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY; TUMOR MICROENVIRONMENT; ANIMAL; CHEMISTRY; GENE THERAPY; GENE TRANSFER; HUMAN; PROCEDURES;

ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; NANOSTRUCTURES; SURFACE PROPERTIES;

EID: 84938065842     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.07.014     Document Type: Review

References (113)

1. E.E. Fullerton, and I.K. Schuller The 2007 Nobel Prize in Physics: magnetism and transport at the nanoscale ACS Nano 1 2007 384 389 10.1021/nn700422j
2. H.Y. Mao, S. Laurent, W. Chen, O. Akhavan, M. Imani, A.A. Ashkarran, and M. Mahmoudi Graphene: promises, facts, opportunities, and challenges in nanomedicine Chem. Rev. 113 2013 3407 3424 10.1021/cr300335p
3. M. Segev-Bar, and H. Haick Flexible sensors based on nanoparticles ACS Nano 7 2013 8366 8378 10.1021/nn402728g
4. J.L. Markman, A. Rekechenetskiy, E. Holler, and J.Y. Ljubimova Nanomedicine therapeutic approaches to overcome cancer drug resistance Adv. Drug Deliv. Rev. 65 2013 1866 1879 10.1016/j.addr.2013.09.019
5. E.K. Chow, and D. Ho Cancer nanomedicine: from drug delivery to imaging Sci. Transl. Med. 5 2013 10.1126/scitranslmed.3005872
6. J.A.H. Junghanns, and R.H. Mueller Nanocrystal technology, drug delivery and clinical applications Int. J. Nanomedicine 3 2008 295 309 10.2147/IJN.S595
7. J. Wright Nanotechnology: deliver on a promise Nature 509 2014 S58 S59 10.1038/509S58a
8. J.H. Adair, M.P. Parette, E.I. Altinoglu, and M. Kester Nanoparticulate alternatives for drug delivery ACS Nano 4 2010 4967 4970 10.1021/nn102324e
9. Y. Barenholz Doxil(R) - the first FDA-approved nano-drug: lessons learned J. Control. Release 160 2012 117 134 10.1016/j.jconrel.2012.03.020
10. R. Haag, and F. Kratz Polymer therapeutics: concepts and applications Angew. Chem. Int. Ed. 45 2006 1198 1215 10.1002/anie.200502113
11. M.L. Etheridge, S.A. Campbell, A.G. Erdman, C.L. Haynes, S.M. Wolf, and J. McCullough The big picture on nanomedicine: the state of investigational and approved nanomedicine products Nanomedicine 9 2013 1 14 10.1016/j.nano.2012.05.013
12. D. Mishra, J.R. Hubenak, and A.B. Mathur Nanoparticle systems as tools to improve drug delivery and therapeutic efficacy J. Biomed. Mater. Res. Part A 101 2013 3646 3660 10.1002/jbm.a.34642
13. S.L. Ginn, I.E. Alexander, M.L. Edelstein, M.R. Abedi, and J. Wixon Gene therapy clinical trials worldwide to 2012 - an update J. Gene Med. 15 2013 65 77 10.1002/jgm.2698
14. T.M. Allen, and P.R. Cullis Liposomal drug delivery systems: from concept to clinical applications Adv. Drug Deliv. Rev. 65 2013 36 48 10.1016/j.addr.2012.09.037
15. V. Wagner, A. Dullaart, A.K. Bock, and A. Zweck The emerging nanomedicine landscape Nat. Biotechnol. 24 2006 1211 1217 10.1038/nbt1006-1211
16. S. Cecco, M. Aliberti, P. Baldo, E. Giacomin, and R. Leone Safety and efficacy evaluation of albumin-bound paclitaxel Expert Opin. Drug Saf. 13 2014 511 520 10.1517/14740338.2014.893293
17. R. Juliano Nanomedicine: is the wave cresting? Nat. Rev. Drug Discov. 12 2013 171 172 10.1038/nrd3958
18. R.K. Jain, and T. Stylianopoulos Delivering nanomedicine to solid tumors Nat. Rev. Clin. Oncol. 7 2010 653 664 10.1038/nrclinonc.2010.139
19. U. Prabhakar, H. Maeda, R.K. Jain, E.M. Sevick-Muraca, W. Zamboni, O.C. Farokhzad, S.T. Barry, A. Gabizon, P. Grodzinski, and D.C. Blakey Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology Cancer Res. 73 2013 2412 2417 10.1158/0008[-]5472.CAN-12-4561
20. M. Belting, S. Sandgren, and A. Wittrup Nuclear delivery of macromolecules: barriers and carriers Adv. Drug Deliv. Rev. 57 2005 505 527 10.1016/j.addr.2004.10.004
21. I.A. Khalil, K. Kogure, H. Akita, and H. Harashima Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery Pharmacol. Rev. 58 2006 32 45 10.1124/pr.58.1.8
22. S.W. Jones, R.A. Roberts, G.R. Robbins, J.L. Perry, M.P. Kai, K. Chen, T. Bo, M.E. Napier, J.P.Y. Ting, J.M. DeSimone, and J.E. Bear Nanoparticle clearance is governed by Th1/Th2 immunity and strain background J. Clin. Invest. 123 2013 3061 3073 10.1172/JCI66895
23. F. Alexis, E. Pridgen, L.K. Molnar, and O.C. Farokhzad Factors affecting the clearance and biodistribution of polymeric nanoparticles Mol. Pharm. 5 2008 505 515 10.1021/mp800051m
24. S.M. Moghimi, A.C. Hunter, and J.C. Murray Long-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 2001 283 318
25. X. Zhang, X. Xu, N. Bertrand, E. Pridgen, A. Swami, and O.C. Farokhzad Interactions of nanomaterials and biological systems: implications to personalized nanomedicine Adv. Drug Deliv. Rev. 64 2012 1363 1384 10.1016/j.addr.2012.08.005
26. J.L. Perry, K.G. Reuter, M.P. Kai, K.P. Herlihy, S.W. Jones, J.C. Luft, M. Napier, J.E. Bear, and J.M. DeSimone PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics Nano Lett. 12 2012 5304 5310 10.1021/nl302638g
27. K.M. Laginha, S. Verwoert, G. Charrois, and T.M. Allen Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors Clin. Cancer Res. 11 2005 6944 6949 10.1158/1078[-]0432.CCR-05-0343
28. N. Staropoli, D. Ciliberto, C. Botta, L. Fiorillo, A. Grimaldi, S. Lama, M. Caraglia, A. Salvino, P. Tassone, and P. Tagliaferri Pegylated liposomal doxorubicin in the management of ovarian cancer: a systematic review and metaanalysis of randomized trials Cancer Biol. Ther. 15 2014 707 720 10.4161/cbt.28557
29. D. Pozzi, V. Colapicchioni, G. Caracciolo, S. Piovesana, A.L. Capriotti, S. Palchetti, S. De Grossi, A. Riccioli, H. Amenitsch, and A. Lagana Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells Nanoscale 6 2014 2782 2792 10.1039/c3nr05559k
30. S. Li, and L. Huang Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting J. Control. Release 145 2010 178 181 10.1016/j.jconrel.2010.03.016
31. H. Hatakeyama, H. Akita, and H. Harashima A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma Adv. Drug Deliv. Rev. 63 2011 152 160 10.1016/j.addr.2010.09.001
32. K. Remaut, B. Lucas, K. Braeckmans, J. Demeester, and S.C. De Smedt Pegylation of liposomes favours the endosornal degradation of the delivered phosphodiester oligonucleotides J. Control. Release 117 2007 256 266 10.1016/j.jconrel.2006.10.029
33. J. Lin, and A. Alexander-Katz Cell membranes open "doors" for cationic nanoparticles/biomolecules: insights into uptake kinetics ACS Nano 7 2013 10799 10808 10.1021/nn4040553
34. P. Xu, G. Bajaj, T. Shugg, W.G. Van Alstine, and Y. Yeo Zwitterionic chitosan derivatives for pH-sensitive stealth coating Biomacromolecules 11 2010 2352 2358 10.1021/bm100481r
35. B. Ozpolat, A.K. Sood, and G. Lopez-Berestein Liposomal siRNA nanocarriers for cancer therapy Adv. Drug Deliv. Rev. 66 2014 110 116 10.1016/j.addr.2013.12.008
36. N. Juliane, and F.C. Szoka Nucleic acid delivery: the missing pieces of the puzzle? Acc. Chem. Res. 45 2012 1153 1162 10.1021/ar3000162
37. D. Fischer, Y.X. Li, B. Ahlemeyer, J. Krieglstein, and T. Kissel In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis Biomaterials 24 2003 1121 1131 10.1016/S0142-9612(02)00445-3
38. K.R. Vega-Villa, J.K. Takemoto, J.A. Yanez, C.M. Remsberg, M.L. Forrest, and N.M. Davies Clinical toxicities of nanocarrier systems Adv. Drug Deliv. Rev. 60 2008 929 938 10.1016/j.addr.2007.11.007
39. Y. Zhao, Y. Qin, Y. Liang, H. Zou, X. Peng, H. Huang, M. Lu, and M. Feng Salt-induced stability and serum-resistance of polyglutamate polyelectrolyte brushes/nuclear factor-kappaB p65 siRNA Polyplex enhance the apoptosis and efficacy of doxorubicin Biomacromolecules 14 2013 1777 1786 10.1021/bm400177q
40. M.E. Davis, J.E. Zuckerman, C.H.J. Choi, D. Seligson, A. Tolcher, C.A. Alabi, Y. Yen, J.D. Heidel, and A. Ribas Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles Nature 464 2010 1067 1140 10.1038/nature08956
41. M. Jayaraman, S.M. Ansell, B.L. Mui, Y.K. Tam, J. Chen, X. Du, D. Butler, L. Eltepu, S. Matsuda, J.K. Narayanannair, K.G. Rajeev, I.M. Hafez, A. Akinc, M.A. Maier, M.A. Tracy, P.R. Cullis, T.D. Madden, M. Manoharan, and M.J. Hope Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo Angew. Chem. Int. Ed. 51 2012 8529 8533 10.1002/anie.201203263
42. S.A. Barros, and J.A. Gollob Safety profile of RNAi nanomedicines Adv. Drug Deliv. Rev. 64 2012 1730 1737 10.1016/j.addr.2012.06.007
43. K. Fitzgerald, M. Frank-Kamenetsky, S. Shulga-Morskaya, A. Liebow, B.R. Bettencourt, J.E. Sutherland, R.M. Hutabarat, V.A. Clausen, V. Karsten, J. Cehelsky, S.V. Nochur, V. Kotelianski, J. Horton, T. Mant, J. Chiesa, J. Ritter, M. Munisamy, A.K. Vaishnaw, J.A. Gollob, and A. Simon Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial Lancet 383 2014 60 68 10.1016/S0140-6736(13)61914-5
44. T. Coelho, D. Adams, A. Silva, P. Lozeron, P.N. Hawkins, T. Mant, J. Perez, J. Chiesa, S. Warrington, E. Tranter, M. Munisamy, R. Falzone, J. Harrop, J. Cehelsky, B.R. Bettencourt, M. Geissler, J.S. Butler, A. Sehgal, R.E. Meyers, Q. Chen, T. Borland, R.M. Hutabarat, V.A. Clausen, R. Alvarez, K. Fitzgerald, C. Gamba-Vitalo, S.V. Nochur, A.K. Vaishnaw, D.W.Y. Sah, J.A. Gollob, and O.B. Suhr Safety and efficacy of RNAi therapy for transthyretin amyloidosis N. Engl. J. Med. 369 2013 819 829 10.1056/NEJMoa1208760
45. J. Tabernero, G.I. Shapiro, P.M. LoRusso, A. Cervantes, G.K. Schwartz, G.J. Weiss, L. Paz-Ares, D.C. Cho, J.R. Infante, M. Alsina, M.M. Gounder, R. Falzone, J. Harrop, A.C.S. White, I. Toudjarska, D. Bumcrot, R.E. Meyers, G. Hinkle, N. Svrzikapa, R.M. Hutabarat, V.A. Clausen, J. Cehelsky, S.V. Nochur, C. Gamba-Vitalo, A.K. Vaishnaw, D.W.Y. Sah, J.A. Gollob, and H.A.I. Burris First-in-Humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement Cancer Discov. 3 2013 406 417 10.1158/2159-8290.CD-12-0429
46. J.C. Burnett, J.J. Rossi, and K. Tiemann Current progress of siRNA/shRNA therapeutics in clinical trials Biotechnol. J. 6 2011 1130 1146 10.1002/biot.201100054
47. T.W. Geisbert, A.C.H. Lee, M. Robbins, J.B. Geisbert, A.N. Honko, V. Sood, J.C. Johnson, S. de Jong, I. Tavakoli, A. Judge, L.E. Hensley, and I. MacLachlan Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study Lancet 375 2010 1896 1905 10.1016/S0140-6736(10)60357-1
48. Z. Xiao, E. Levy-Nissenbaum, F. Alexis, A. Luptak, B.A. Teply, J.M. Chan, J. Shi, E. Digga, J. Cheng, R. Langer, and O.C. Farokhzad Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection ACS Nano 6 2012 696 704 10.1021/nn204165v
49. R. van der Meel, L.J. Vehmeijer, R.J. Kok, G. Storm, and E.V. van Gaal Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status Adv. Drug Deliv. Rev. 65 2013 1284 1298 10.1016/j.addr.2013.08.012
50. M. Talelli, S. Oliveira, C.J.F. Rijcken, E.H.E. Pieters, T. Etrych, K. Ulbrich, R.C.F. van Nostrum, G. Storm, W.E. Hennink, and T. Lammers Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy Biomaterials 34 2013 1255 1260 10.1016/j.biomaterials.2012.09.064
51. Y. Oe, R.J. Christie, M. Naito, S.A. Low, S. Fukushima, K. Toh, Y. Miura, Y. Matsumoto, N. Nishiyama, K. Miyata, and K. Kataoka Actively-targeted polyion complex micelles stabilized by cholesterol and disulfide cross-linking for systemic delivery of siRNA to solid tumors Biomaterials 35 2014 7887 7895 10.1016/j.biomaterials.2014.05.041
52. A.M. Master, and A. Sen Gupta EGF receptor-targeted nanocarriers for enhanced cancer treatment Nanomedicine 7 2012 1895 1906 10.2217/NNM.12.160
53. G.T. Noble, J.F. Stefanick, J.D. Ashley, T. Kiziltepe, and B. Bilgicer Ligand-targeted liposome design: challenges and fundamental considerations Trends Biotechnol. 32 2014 32 45 10.1016/j.tibtech.2013.09.007
54. C.H.J. Choi, C.A. Alabi, P. Webster, and M.E. Davis Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles Proc. Natl. Acad. Sci. U. S. A. 107 2010 1235 1240 10.1073/pnas.0914140107
55. D.W. Bartlett, H. Su, I.J. Hildebrandt, W.A. Weber, and M.E. Davis Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging Proc. Natl. Acad. Sci. U. S. A. 104 2007 15549 15554 10.1073/pnas.0707461104
56. D.B. Kirpotin, D.C. Drummond, Y. Shao, M.R. Shalaby, K. Hong, U.B. Nielsen, J.D. Marks, C.C. Benz, and J.W. Park Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res. 66 2006 6732 6740 10.1158/0008[-]5472.CAN-05-4199
57. W.W. Cheng, and T.M. Allen Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab′ fragments and single chain Fv J. Control. Release 126 2008 50 58 10.1016/j.jconrel.2007.11.005
58. K.M. McNeeley, A. Annapragada, and R.V. Bellamkonda Decreased circulation time offsets increased efficacy of PEGylated nanocarriers targeting folate receptors of glioma Nanotechnology 18 2007 385101 10.1088/0957[-]4484/18/38/385101
59. G.K. Pombo, K. Zarschler, L. Barbaro, J.A. Barreto, W. O'Malley, L. Spiccia, H. Stephan, and B. Graham Zwitterionic-coated "stealth" nanoparticles for biomedical applications: recent advances in countering biomolecular corona formation and uptake by the mononuclear phagocyte system Small 10 2014 2516 2529 10.1002/smll.201303540
60. Z. Amoozgar, and Y. Yeo Recent advances in stealth coating of nanoparticle drug delivery systems Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4 2012 219 233 10.1002/wnan.1157
61. Q. Sun, M. Radosz, and Y. Shen Challenges in design of translational nanocarriers J. Control. Release 164 2012 156 169 10.1016/j.jconrel.2012.05.042
62. L. Mi, and S. Jiang Integrated antimicrobial and nonfouling zwitterionic polymers Angew. Chem. Int. Ed. 53 2014 1746 1754 10.1002/anie.201304060
63. S. Jiang, and Z. Cao Ultralow-fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications Adv. Mater. 22 2010 920 932 10.1002/adma.200901407
64. L. Lartigue, C. Wilhelm, J. Servais, C. Factor, A. Dencausse, J.C. Bacri, N. Luciani, and F. Gazeau Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: impact on macrophage uptake ACS Nano 6 2012 2665 2678 10.1021/nn300060u
65. Y.Y. Yuan, C.Q. Mao, X.J. Du, F. Wang Du JZ, and J. Wang Surface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumor Adv. Mater. 24 2012 5476 5480 10.1002/adma.201202296
66. X. Liu, Q. Jin, Y. Ji, and J. Ji Minimizing nonspecific phagocytic uptake of biocompatible gold nanoparticles with mixed charged zwitterionic surface modification J. Mater. Chem. 22 2012 1916 1927 10.1039/c1jm14178c
67. J.E. Rosen, and F.X. Gu Surface functionalization of silica nanoparticles with cysteine: a low-fouling zwitterionic surface Langmuir 27 2011 10507 10513 10.1021/la201940r
68. J. Ladd, Z. Zhang, S. Chen, J.C. Hower, and S. Jiang Zwitterionic polymers exhibiting high resistance to nonspecific protein adsorption from human serum and plasma Biomacromolecules 9 2008 1357 1361 10.1021/bm701301s
69. A. Li, H.P. Luehmann, G. Sun, S. Samarajeewa, J. Zou, S. Zhang, F. Zhang, M.J. Welch, Y. Liu, and K.L. Wooley Synthesis and in vivo pharmacokinetic evaluation of degradable shell cross-linked polymer nanoparticles with poly(carboxybetaine) versus poly(ethylene glycol) surface-grafted coatings ACS Nano 6 2012 8970 8982 10.1021/nn303030t
70. Z.G. Estephan, P.S. Schlenoff, and J.B. Schlenoff Zwitteration as an alternative to PEGylation Langmuir 27 2011 6794 6800 10.1021/la200227b
71. M. Xu, Y. Zhao, and M. Feng Polyaspartamide derivative nanoparticles with tunable surface charge achieve highly efficient cellular uptake and low cytotoxicity Langmuir 28 2012 11310 11318 10.1021/la3025028
72. K.C. Liu, and Y. Yeo Zwitterionic chitosan-polyamidoamine dendrimer complex nanoparticles as a pH-sensitive drug carrier Mol. Pharm. 10 2013 1695 1704 10.1021/mp300522p
73. R. Mo, Q. Sun, N. Li, and C. Zhang Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids Biomaterials 34 2013 2773 2786 10.1016/j.biomaterials.2013.01.030
74. Y. Obata, S. Tajima, and S. Takeoka Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo J. Control. Release 142 2010 267 276 10.1016/j.jconrel.2009.10.023
75. Y. Li, Q. Cheng, Q. Jiang, Y. Huang, H. Liu, Y. Zhao, W. Cao, G. Ma, F. Dai, X. Liang, Z. Liang, and X. Zhang Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA J. Control. Release 176 2014 104 114 10.1016/j.jconrel.2013.12.007
76. B. Zhao, and W.J. Brittain Polymer brushes: surface-immobilized macromolecules Prog. Polym. Sci. 25 2000 677 710 10.1016/S0079-6700(00)00012-5
77. C. Pastorino, K. Binder, T. Kreer, and M. Muller Static and dynamic properties of the interface between a polymer brush and a melt of identical chains J. Chem. Phys. 124 2006 64902 10.1063/1.2162883
78. B. Zdyrko, and I. Luzinov Polymer brushes by the 'grafting to' method Macromol. Rapid Comm. 32 2011 859 869 10.1002/marc.201100162
79. R. Barbey, L. Lavanant, D. Paripovic, N. Schuwer, C. Sugnaux, S. Tugulu, and H.A. Klok Polymer brushes via surface-initiated controlled radical polymerization: synthesis, characterization, properties, and applications Chem. Rev. 109 2009 5437 5527 10.1021/cr900045a
80. L. Ionov, and S. Minko Mixed polymer brushes with locking switching ACS Appl. Mater. Interfaces 4 2012 483 489 10.1021/am201736t
81. M.A. Stuart, W.T. Huck, J. Genzer, M. Muller, C. Ober, M. Stamm, G.B. Sukhorukov, I. Szleifer, V.V. Tsukruk, M. Urban, F. Winnik, S. Zauscher, I. Luzinov, and S. Minko Emerging applications of stimuli-responsive polymer materials Nat. Mater. 9 2010 101 113 10.1038/nmat2614
82. H. Merlitz, G.L. He, C.X. Wu, and J.U. Sommer Nanoscale brushes: how to build a smart surface coating Phys. Rev. Lett. 102 2009 115702 10.1103/PhysRevLett.102.115702
83. M. Motornov, T.K. Tam, M. Pita, I. Tokarev, E. Katz, and S. Minko Switchable selectivity for gating ion transport with mixed polyelectrolyte brushes: approaching 'smart' drug delivery systems Nanotechnology 20 2009 434006 10.1088/0957[-]4484/20/43/434006
84. M.S. Yavuz, Y. Cheng, J. Chen, C.M. Cobley, Q. Zhang, M. Rycenga, J. Xie, C. Kim, K.H. Song, A.G. Schwartz, L.V. Wang, and Y. Xia Gold nanocages covered by smart polymers for controlled release with near-infrared light Nat. Mater. 8 2009 935 939 10.1038/nmat2564
85. K. Ohno, C. Mori, T. Akashi, S. Yoshida, Y. Tago, Y. Tsujii, and Y. Tabata Fabrication of contrast agents for magnetic resonance imaging from polymer-brush-afforded iron oxide magnetic nanoparticles prepared by surface-initiated living radical polymerization Biomacromolecules 14 2013 3453 3462 10.1021/bm400770n
86. C. Alvarez-Lorenzo, and A. Concheiro Smart drug delivery systems: from fundamentals to the clinic Chem. Commun. 50 2014 7743 7765 10.1039/c4cc01429d
87. P.T. Hammond Thin films: particles release Nat. Mater. 9 2010 292 293 10.1038/nmat2738
88. K. Ariga, Y.M. Lvov, K. Kawakami, Q. Ji, and J.P. Hill Layer-by-layer self-assembled shells for drug delivery Adv. Drug Deliv. Rev. 63 2011 762 771 10.1016/j.addr.2011.03.016
89. A.L. Becker, A.P.R. Johnston, and F. Caruso Layer-by-layer-assembled capsules and films for therapeutic delivery Small 6 2010 1836 1852 10.1002/smll.201000379
90. V. Vergaro, F. Scarlino, C. Bellomo, R. Rinaldi, D. Vergara, M. Maffia, F. Baldassarre, G. Giannelli, X. Zhang, Y.M. Lvov, and S. Leporatti Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells Adv. Drug Deliv. Rev. 63 2011 847 864 10.1016/j.addr.2011.05.007
91. Z. Chen, L. Zhang, Y. He, Y. Shen, and Y. Li Enhanced shRNA delivery and ABCG2 silencing by charge-reversible layered nanocarriers Small 11 2015 952 962 10.1002/smll.201401397
92. L. Han, J. Zhao, X. Zhang, W. Cao, X. Hu, G. Zou, X. Duan, and X. Liang Enhanced siRNA delivery and silencing Gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility ACS Nano 6 2012 7340 7351 10.1021/nn3024688
93. E.C. Dreaden, S.W. Morton, K.E. Shopsowitz, J. Choi, Z.J. Deng, N. Cho, and P.T. Hammond Bimodal tumor-targeting from microenvironment responsive hyaluronan layer-by-layer (LbL) nanoparticles ACS Nano 8 2014 8374 8382 10.1021/nn502861t
94. N. Song, M. Ding, Z. Pan, J. Li, L. Zhou, H. Tan, and Q. Fu Construction of targeting-clickable and tumor-cleavable polyurethane nanomicelles for multifunctional intracellular drug delivery Biomacromolecules 14 2013 4407 4419 10.1021/bm401342t
95. J. Zheng, Y. Wan, A. Elhissi, Z. Zhang, and X. Sun Targeted paclitaxel delivery to tumors using cleavable PEG-conjugated solid lipid nanoparticles Pharm. Res. 31 2014 2220 2233 10.1007/s11095-014-1320-8
96. E. Koren, A. Apte, A. Jani, and V.P. Torchilin Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity J. Control. Release 160 2012 264 273 10.1016/j.jconrel.2011.12.002
97. H. Takemoto, K. Miyata, S. Hattori, T. Ishii, T. Suma, S. Uchida, N. Nishiyama, and K. Kataoka Acidic pH-Responsive siRNA conjugate for reversible carrier stability and accelerated endosomal escape with reduced IFNα-Associated immune response Angew. Chem. 125 2013 6338 6341 10.1002/ange.201300178
98. S. Chen, J. Zheng, L. Li, and S. Jiang Strong resistance of phosphorylcholine self-assembled monolayers to protein adsorption: insights into nonfouling properties of zwitterionic materials J. Am. Chem. Soc. 127 2005 14473 14478 10.1021/ja054169u
99. J.B. Schlenoff Zwitteration: coating surfaces with zwitterionic functionality to reduce nonspecific adsorption Langmuir 30 2014 9625 9636 10.1021/la500057j
100. H. Groult, J. Ruiz-Cabello, A.V. Lechuga-Vieco, J. Mateo, M. Benito, I. Bilbao, M.P. Martinez-Alcazar, J.A. Lopez, J. Vazquez, and F.F. Herranz Phosphatidylcholine-coated iron oxide nanomicelles for in vivo prolonged circulation time with an antibiofouling protein corona Chemistry 20 2014 16662 16671 10.1002/chem.201404221
101. Y. Wen, Z. Zhang, and J. Li Highly efficient multifunctional supramolecular gene carrier system self-assembled from redox-sensitive and zwitterionic polymer blocks Adv. Funct. Mater. 24 2014 3874 3884 10.1002/adfm.201303687
102. M. Motornov, R. Sheparovych, I. Tokarev, Y. Roiter, and S. Minko Nonwettable thin films from hybrid polymer brushes can be hydrophilic Langmuir 23 2007 13 19 10.1021/la061737q
103. A. Olivier, F. Meyer, J. Raquez, P. Damman, and P. Dubois Surface-initiated controlled polymerization as a convenient method for designing functional polymer brushes: from self-assembled monolayers to patterned surfaces Prog. Polym. Sci. 37 2012 157 181 10.1016/j.progpolymsci.2011.06.002
104. T. Chen, R. Ferris, J. Zhang, R. Ducker, and S. Zauscher Stimulus-responsive polymer brushes on surfaces: transduction mechanisms and applications Prog. Polym. Sci. 35 2010 94 112 10.1016/j.progpolymsci.2009.11.004
105. J. Cui, N. Thi-Huong, M. Ceolin, R. Berger, O. Azzaroni, and A. Del Campo Phototunable response in caged polymer brushes Macromolecules 45 7 2012 3213 3220 10.1021/ma300274b
106. H. Lee, J. Pietrasik, S.S. Sheiko, and K. Matyjaszewski Stimuli-responsive molecular brushes Prog. Polym. Sci. 35 2010 24 44 10.1016/j.progpolymsci.2009.11.002
107. N. Schuwer, and H.A. Klok Tuning the pH sensitivity of poly(methacrylic acid) brushes Langmuir 27 2011 4789 4796 10.1021/la200347u
108. X. Sui, S. Zapotoczny, E.M. Benetti, M. Memesa, M.A. Hempenius, and G.J. Vancso Grafting mixed responsive brushes of poly(N-isopropylacrylamide) and poly(methacrylic acid) from gold by selective initiation Polym. Chem. 2 2011 879 884 10.1039/c0py00393j
109. Z. Poon, D. Chang, X. Zhao, and P.T. Hammond Layer-by-layer nanoparticles with a pH-sheddable layer for in vivo targeting of tumor hypoxia ACS Nano 5 2011 4284 4292 10.1021/nn200876f
110. X.Z. Yang, J.Z. Du, S. Dou, C.Q. Mao, H.Y. Long, and J. Wang Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery ACS Nano 6 2012 771 781 10.1021/nn204240b
111. W. Gao, J.M. Chan, and O.C. Farokhzad pH-responsive nanoparticles for drug delivery Mol. Pharm. 7 2010 1913 1920 10.1021/mp100253e
112. X. Zhang, S. Malhotra, M. Molina, and R. Haag Micro- and nanogels with labile crosslinks - from synthesis to biomedical applications Chem. Soc. Rev. 44 2015 1948 1973 10.1039/c4cs00341a
113. T.C. Lai, Y. Bae, T. Yoshida, K. Kataoka, and G.S. Kwon pH-sensitive multi-PEGylated block copolymer as a bioresponsive pDNA delivery vector Pharm. Res. 27 2010 2260 2273 10.1007/s11095-010-0092-z